Opinion
MISC. CASE NO. 6:17-mc-00086
05-09-2017
NANCY C. BRUNKEN AS ADMINISTRATOR OF THE ESTATE OF EDWARD BRUNKEN v. TAKEDA PHARMACEUTICALS AMERICA, INC. et al.
JUDGE DOHERTY
. REPORT AND RECOMMENDATIONS ON UNOPPOSED MOTION FOR SETTLEMENT AS TO CLAIMS OF DECEDENT , EDWARD BRUNKEN
This Court, having reviewed Plaintiffs' Unopposed Motion to Approve Settlement as to Claims of Nancy Carole Brunken, as Administrator and Derivative Claimant; and Jason Brunken and Steffanie Bush as Derivative Claimant and Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. (collectively "Takeda"), the parties having received due notice of and having had the opportunity to be heard, and this Court having considered all submissions made, I recommend to the Court that the Motion be
GRANTED and
The settlement by and between Plaintiffs, Nancy Carole Brunken, as Administrator and Derivative Claimant; and Jason Brunken and Steffanie Bush as Derivative Claimant individually and as legal heirs to the Estate of Edward Brunken, deceased, and Takeda, as notice to the Court on May 5, 2017 be
APPROVED.
The Court has jurisdiction of this matter by virtue of the Plaintiffs participating in the Actos MDL Master Settlement Agreement.
ANY PARTY OBJECTING TO THIS RECOMMENDATION SHALL SUBMIT OBJECTIONS, IN WRITING, DIRECTLY TO JUDGE DOHERTY'S CHAMBERS - AND SHALL NOT FILE THE OBJECTION INTO THE RECORD - NO LATER THAN TEN (10) DAYS AFTER ENTRY OF THIS RECOMMENDATION.
If there is no objection within ten (10) days of the entry of this Recommendation, the Recommendation will become an Order.
This is DONE AND SIGNED in Lafayette, Louisiana, this 9th day of May 2017.
/s/_________
HONORABLE PATRICK J. HANNA
UNITED STATES MAGISTRATE JUDGE